Authors: Schwieterman, WD Weiss, KD Tiwari, J Siegel, JP

Citation: Wd. Schwieterman et al., Changes in trial parameters, LANCET, 357(9252), 2001, pp. 314-314

Authors: Keane, J Gershon, S Wise, RP Mirabile-Levens, E Kasznica, J Schwieterman, WD Siegel, JN Braun, MM

Citation: J. Keane et al., Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent, N ENG J MED, 345(15), 2001, pp. 1098-1104

Authors: Schwieterman, WD

Citation: Wd. Schwieterman, FDA perspective on anti-TNF treatments, ANN RHEUM D, 58, 1999, pp. 90-91